Polycystic Ovary Syndrome (PCOS) as the most common abnormality of endocrine system is defined with hyperandrogenism and anovulation (1). The pathophysiology of PCOS is poorly understood (1, 2). The role of several candidate genes and gene polymorphisms has been studied in PCOS regarding calcium homeostasis-dependent process, steroidogenesis, and pathways of insulin signaling (2). The insulin receptor (INSR) gene is mapped to chromosome 19p13.3-p13.2 (3). The INSR gene has several genetic polymorphisms and was recognized to be associated with PCOS and insulin resistance (IR) (3–8). The relationship between INSR gene variants and PCOS is still controversial (9). Ranjzad et al. (2010) showed that there are no statistically significant differences between the PCOS women and controls regarding the studied markers in the vitamin D receptor (VDR), parathyroid hormone (PTH), insulin receptor (INSR), and adiponectin (ADIPOQ) genes for VDR/Tru9I (rs757343), PTH/ DraII (rs6256), INSR/NsiI (rs2059806), INSR/ PmlI (rs1799817), and ADIPOQ/BsmI (rs1501299) single nucleotide polymorphisms (SNPs) (10). The INSR gene has a central role in hyperinsulinemia and IR predisposition (9–11). IR leads to reproductive problems in PCOS women (12–14). Considering diverse ethnicities in Iran, an attempt was made in this study to determine the frequency of INSR gene polymorphisms in PCOS women and normal controls.

This study was performed in Urmia University of Medical Sciences. During the period of 2011-2013, 50 PCOS women and 47 controls entered the study. The ethics committee of Urmia University of Medical Sciences approved this investigation. PCOS women and controls were genetically unrelated, whereas matched regarding ethnicity, geographical region and age. All subjects underwent various tests in ART Reproductive Center and Infertility Clinic by related specialists. Same physicians evaluated medical history, physical and clinical examinations for all individuals. PCOS women were diagnosed based on the finding of three or more of the criteria as proposed by the Rotterdam criteria (15) and National Institute of Child Health and Human Development (NICHD) (16). Confounding features such as oligomenorrhea, amenorrhea, hyperandrogenism (non-classic congenital adrenal hyperplasia), and hyperprolactinaemia as well as participants taking drugs affecting calcium homeostasis were excluded from the analysis (10). All subjects signed informed consents. Genomic DNA was isolated from 3-5 ml of whole blood using “salting out” method (17). NsiI (rs2059806) and PmlI (rs1799817) SNPs were genotyped by RFLP-PCR. PCR was carried out in 25 µl solution using 100 ng of DNA, 1x reaction buffer, 10 pmol of each primer (INSR/NsiI (rs 2059806): 5′-cggtcttg taagggtaactg-3′ and 5′-gaatt cacattcccaagaca-3′; INSR/PmlI (rs1799817): 5′-cc aaggatgctgtgtagataa g-3′ and 5′-tcaggaaagccagccc atgtc-3′), 200 µmol of each dNTPs, 0.5 unit of Taq DNA polymerase, and 1.5 mmol MgCl₂ under 35 cycles of PCR program (93°C 45 s, 56°C 30 s, 72°C 45 s) (10). The PCR leads to the formation of a 324 and 317 bp amplicon in the cases of INSR/NsiI (rs2059806) and INSR/PmlI (rs1799817) SNPs, respectively. 10 µl of PCR products were digested by 10 units of NsiI and PmlI restriction enzymes (Fermentas, Stockholm, Sweden) by incubating the samples at 37°C for 4 hr in two separate reactions. When an A allele was present in NsiI SNP (rs2059806) within the exon 8 (A/G) of the INSR gene, the NsiI enzyme yielded 239 and 89 bp fragments on the agarose gel. The PCR products remained uncut (324 bp) in the presence of the NsiI enzyme, confirming the presence of a G allele in this locus. When a C allele was present in PmlI SNP (rs1799817) within the exon 17 (T/C) of the INSR gene, the PmlI enzyme yielded 274 and 43 bp fragments on the agarose gel. The PCR products remained un-cut (317 bp) in the presence of the PmlI enzyme, confirming the presence of a T allele in this locus. NsiI/PmlI based RFLPs were analyzed by electrophoresis on 2.5% agarose gel containing ethidium bromide stain. UV transilluminator was used for monitoring presence or absence of tested alleles. Genotypic and allelic frequencies were counted directly. Hardy-Weinberg equilibrium (HWE) test was performed for determination of deviation of genotype distribution.

Genotypic and allelic frequencies of NsiI SNP within the exon 8 (A/G) and PmlI SNP within the exon 17 (T/C) of the INSR gene in studied groups are summarized in Table 1. Our controls were consistent with HWE regarding NsiI SNP within the exon 8 (A/G) and PmlI SNP within the exon 17 (T/C) of the INSR gene. INSR NsiI-SNP (rs2059806) resulted in three genotypes of GG, GA, and AA with G and A alleles. INSR NsiI-SNP GG, GA, AA, G and A genotypic and allelic frequencies were 45(90%), 5(10%), 0(0%), 95(95%) and 5(5%) in cases and 41(87.2%), 6(12.8%), 0(0%), 88(93.6%) and 6(6.38%) in controls, respectively. INSR PmlI-SNPs (rs1799817) resulted in three genotypes of CC, CT, and TT with C and T alleles. The frequencies of PmlI (rs1799817) SNP in the INSR gene were 37(37%) and 63(63%) in cases, also 39(41.49%) and 55(58.51%) in controls regarding T and C alleles. The frequencies of PmlI (rs 1799817) SNP in the INSR gene were 4(8%), 29(58%), and 17(34%) in cases, also 5(10.64%), 29(61.7%), and 13(27.66%) in controls regarding TT, TC, and CC genotypes, respectively.

PCOS has a variety of etiologies including gene-gene and gene-environment interactions (18). Numerous data support the idea that PCOS has been associated with insulin resistance (19), type 2 diabetes mellitus (20, 21), hyperinsulinemia (22), hyperandrogenism (23, 24), inflammation (25), cardiovascular disease (26, 27), and hypertension (28). PCOS women are mainly diagnosed by hyperandrogenism, menstrual irregularity and infertility (29), and are usually overweight or obese (30). In this case-control study, an attempt was made to investigate whether NsiI/PmlI based SNPs in the INSR gene were associated with PCOS risk. Our findings in the present study showed no statistically significant differences in the allele and genotype frequencies regarding INSR/NsiI (rs2059806) and INSR/PmlI (rs1799817) SNPs between PCOS women and controls. The results of several studies are consistent with our findings (2, 7, 8, 31–33). Investigation of several genes are necessary to understand the pathophysiology of PCOS. Our research had some limitations such as lack of precise data from tested genes, low number of cases and poor quality of registry information. Further studies with big sample size and extra information from other genetic variations and haplotypes are required for supplementary analysis.

This report as the first analysis in its own kind in Iranian Azeri Turkish women showed no statistically significant differences between women with PCOS and controls regarding NsiI (rs2059806) and PmlI (rs1799817) SNPs in the INSR gene.